Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 956071, 16 pages
http://dx.doi.org/10.1155/2010/956071
Review Article

The Structure and Function of Serum Opacity Factor: A Unique Streptococcal Virulence Determinant That Targets High-Density Lipoproteins

1Veterans Affairs Medical Center and Department of Medicine, University of Tennessee Health Science Center, 1030 Jefferson Avenue, Memphis, TN 38104, USA
2Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA

Received 9 April 2010; Accepted 26 May 2010

Academic Editor: Mari A. Smits

Copyright © 2010 Harry S. Courtney and Henry J. Pownall. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. K. Ward and G. V. Rudd, “Studies on haemolytic streptococci from human sources,” Australian Journal of Experimental Biology & Medical Science, vol. 16, pp. 181–192, 1938. View at Google Scholar
  2. E. Krumwiede, “Studies on a lipoproteinase of group A streptococci,” The Journal of Experimental Medicine, vol. 100, no. 6, pp. 629–639, 1954. View at Google Scholar · View at Scopus
  3. R. Rowen, “The release of cholesterol esters from serum lipoproteins by extracts of certain group A streptococci,” Journal of Experimental Medicine, vol. 114, pp. 807–823, 1961. View at Google Scholar
  4. R. Rowen and J. Martin, “Enhancement of cholesterol esterification in serum by an extract of group-A streptococcus,” Biochimica et Biophysica Acta, vol. 70, pp. 396–405, 1963. View at Google Scholar · View at Scopus
  5. G. A. Saravani and D. R. Martin, “Opacity factor from group A streptococci is an apoproteinase,” FEMS Microbiology Letters, vol. 68, no. 1-2, pp. 35–39, 1990. View at Google Scholar · View at Scopus
  6. H. S. Courtney, Y.-M. Zhang, M. W. Frank, and C. O. Rock, “Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure,” Journal of Biological Chemistry, vol. 281, no. 9, pp. 5515–5521, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. K. Gillard, H. S. Courtney, J. B. Massey, and H. J. Pownall, “Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption,” Biochemistry, vol. 46, no. 45, pp. 12968–12978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. W. Cunningham, “Pathogenesis of group a streptococcal infections,” Clinical Microbiology Reviews, vol. 13, no. 3, pp. 470–511, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. H. S. Courtney, D. L. Hasty, and J. B. Dale, “Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci,” Annals of Medicine, vol. 34, no. 2, pp. 77–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Courtney, D. L. Hasty, Y. Li, H. C. Chiang, J. L. Thacker, and J. B. Dale, “Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes,” Molecular Microbiology, vol. 32, no. 1, pp. 89–98, 1999. View at Google Scholar · View at Scopus
  11. C. G. Baums, U. Kaim, M. Fulde, G. Ramachandran, R. Goethe, and P. Valentin-Weigand, “Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis,” Infection and Immunity, vol. 74, no. 11, pp. 6154–6162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Timmer, S. A. Kristian, V. Datta et al., “Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence,” Molecular Microbiology, vol. 62, no. 1, pp. 15–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. S. Courtney, D. L. Hasty, and J. B. Dale, “Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous sof-positive serotypes of group A streptococci,” Infection and Immunity, vol. 71, no. 9, pp. 5097–5103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. D. Rehder, D. R. Johnson, and E. L. Kaplan, “Comparison of methods for obtaining serum opacity factor from group A streptococci,” Journal of Clinical Microbiology, vol. 33, no. 11, pp. 2963–2967, 1995. View at Google Scholar · View at Scopus
  15. D. R. Johnson and E. L. Kaplan, “Microtechnique for serum opacity factor characterization of group A streptococci adaptable to the use of human sera,” Journal of Clinical Microbiology, vol. 26, no. 10, pp. 2025–2030, 1988. View at Google Scholar · View at Scopus
  16. J. V. Rakonjac, J. C. Robbins, and V. A. Fischetti, “DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain,” Infection and Immunity, vol. 63, no. 2, pp. 622–631, 1995. View at Google Scholar · View at Scopus
  17. C. M. Gillen, R. J. Towers, D. J. McMillan et al., “Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor,” Microbiology, vol. 148, no. 1, pp. 169–178, 2002. View at Google Scholar · View at Scopus
  18. J. P. Widdowson, W. R. Maxted, and D. L. Grant, “The production of opacity in serum by group A streptococci and its relationship withthe presence of M antigen,” Journal of General Microbiology, vol. 61, no. 3, pp. 343–353, 1970. View at Google Scholar · View at Scopus
  19. D. R. Johnson and E. L. Kaplan, “A review of the correlation of T-agglutination patterns and M-protein typing and opacity factor production in the identification of group A streptococci,” Journal of Medical Microbiology, vol. 38, no. 5, pp. 311–315, 1993. View at Google Scholar · View at Scopus
  20. W. R. Maxted, J. P. Widdowson, C. A. Fraser, L. C. Ball, and D. C. Bassett, “The use of the serum opacity reaction in the typing of group-A streptococci,” Journal of Medical Microbiology, vol. 6, no. 1, pp. 83–90, 1973. View at Google Scholar · View at Scopus
  21. B. Beall, G. Gherardi, M. Lovgren, R. R. Facklam, B. A. Forwick, and G. J. Tyrrell, “emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci,” Microbiology, vol. 146, no. 5, pp. 1195–1209, 2000. View at Google Scholar · View at Scopus
  22. B. Kreikemeyer, S. R. Talay, and G. S. Chhatwal, “Characterization of a novel fibronectin-binding surface protein in group A streptococci,” Molecular Microbiology, vol. 17, no. 1, pp. 137–145, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Beres, E. W. Richter, M. J. Nagiec et al., “Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7059–7064, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Jeng, V. Sakota, Z. Li, V. Datta, B. Beall, and V. Nizet, “Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX,” Journal of Bacteriology, vol. 185, no. 4, pp. 1208–1217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. N. M. Green, S. Zhang, S. F. Porcella et al., “Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity,” Journal of Infectious Diseases, vol. 192, no. 5, pp. 760–770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. W. M. McShan, J. J. Ferretti, T. Karasawa et al., “Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes,” Journal of Bacteriology, vol. 190, no. 23, pp. 7773–7785, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Katerov, P.-E. Lindgren, A. A. Totolian, and C. Schalén, “Streptococcal opacity factor: a family of bifunctional proteins with lipoproteinase and fibronectin-binding activities,” Current Microbiology, vol. 40, no. 3, pp. 149–156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Kreikemeyer, D. R. Martin, and G. S. Chhatwal, “SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activity,” FEMS Microbiology Letters, vol. 178, no. 2, pp. 305–311, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. P.-E. Lindgren, M. J. McGavin, C. Signas et al., “Two different genes coding for fibronectin-binding proteins from Streptococcus dysgalactiae. The complete nucleotide sequences and characterization of the binding domains,” European Journal of Biochemistry, vol. 214, no. 3, pp. 819–827, 1993. View at Google Scholar · View at Scopus
  30. D. Takamatsu, M. Osaki, P. Tharavichitkul, S. Takai, and T. Sekizaki, “Allelic variation and prevalence of serum opacity factor among the Streptococcus suis population,” Journal of Medical Microbiology, vol. 57, no. 4, pp. 488–494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. E. Wertz, K. F. McGregor, and D. E. Bessen, “Detecting key structural features within highly recombined genes,” PLoS Computational Biology, vol. 3, no. 1, article e14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Ton-That, L. A. Marraffini, and O. Schneewind, “Protein sorting to the cell wall envelope of Gram-positive bacteria,” Biochimica et Biophysica Acta, vol. 1694, no. 1–3, pp. 269–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Whittaker and R. O. Hynes, “Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere,” Molecular Biology of the Cell, vol. 13, no. 10, pp. 3369–3387, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. G. A. Saravani and D. R. Martin, “Characterisation of opacity factor from group-A streptococci,” Journal of Medical Microbiology, vol. 33, no. 1, pp. 55–60, 1990. View at Google Scholar · View at Scopus
  35. H. J. Pownall, “Remodeling of human plasma lipoproteins by detergent perturbation,” Biochemistry, vol. 44, no. 28, pp. 9714–9722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. H. J. Pownall, B. D. Hosken, B. K. Gillard, C. L. Higgins, H. Y. Lin, and J. B. Massey, “Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning,” Biochemistry, vol. 46, no. 25, pp. 7449–7459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Mehta, D. L. Gantz, and O. Gursky, “Human plasma high-density lipoproteins are stabilized by kinetic factors,” Journal of Molecular Biology, vol. 328, no. 1, pp. 183–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Han, B. K. Gillard, H. S. Courtney et al., “Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I,” Biochemistry, vol. 48, no. 7, pp. 1481–1487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Rosales, B. K. Gillard, H. S. Courtney, F. Blanco-Vaca, and H. J. Pownall, “Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins,” Biochemistry, vol. 48, no. 33, pp. 8070–8076, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Oehmcke, A. Podbielski, and B. Kreikemeyer, “Function of the fibronectin-binding serum opacity factor of Streptococcus pyogenes in adherence to epithelial cells,” Infection and Immunity, vol. 72, no. 7, pp. 4302–4308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Gillen, H. S. Courtney, K. Schulze et al., “Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete,” Journal of Biological Chemistry, vol. 283, no. 10, pp. 6359–6366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. R. Talay, A. Zock, M. Rohde et al., “Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells,” Cellular Microbiology, vol. 2, no. 6, pp. 521–535, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Balbona, H. Tran, S. Godyna, K. C. Ingham, D. K. Strickland, and W. S. Argraves, “Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin,” Journal of Biological Chemistry, vol. 267, no. 28, pp. 20120–20125, 1992. View at Google Scholar · View at Scopus
  44. B. R. Tomasini-Johansson, N. R. Kaufman, M. G. Ensenberger, V. Ozeri, E. Hanski, and D. F. Mosher, “A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly,” Journal of Biological Chemistry, vol. 276, no. 26, pp. 23430–23439, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. P. E. Dombek, D. Cue, J. Sedgewick et al., “High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements,” Molecular Microbiology, vol. 31, no. 3, pp. 859–870, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. H. S. Courtney and A. Podbielski, “Group A Streptococcal invasion of host cells,” in Bacterial Invasion of Host Cells, R. J. Lamont, Ed., pp. 239–273, Cambridge University Press, Cambridge, UK, 2004. View at Google Scholar
  47. A. Kalia and D. E. Bessen, “Natural selection and evolution of Streptococcal virulence genes involved in tissue-specific adaptations,” Journal of Bacteriology, vol. 186, no. 1, pp. 110–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. D. E. Bessen, C. M. Sotir, T. L. Readdy, and S. K. Hollingshead, “Genetic correlates of throat and skin isolates of group A streptococci,” Journal of Infectious Diseases, vol. 173, no. 4, pp. 896–900, 1996. View at Google Scholar · View at Scopus
  49. H. S. Courtney, Y. Li, W. O. Twal, and W. S. Argraves, “Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1,” Journal of Biological Chemistry, vol. 284, no. 19, pp. 12966–12971, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. W. S. Argraves, L. M. Greene, M. A. Cooley, and W. M. Gallagher, “Fibulins: physiological and disease perspectives,” EMBO Reports, vol. 4, no. 12, pp. 1127–1131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. S. de Vega, T. Iwamoto, and Y. Yamada, “Fibulins: multiple roles in matrix structures and tissue functions,” Cellular and Molecular Life Sciences, vol. 66, no. 11-12, pp. 1890–1902, 2009. View at Google Scholar · View at Scopus
  52. H. S. Courtney, J. B. Dale, and D. L. Hasty, “Mapping the fibrinogen-binding domain of serum opacity factor of group A streptococci,” Current Microbiology, vol. 44, no. 4, pp. 236–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. H. S. Courtney, D. L. Hasty, and J. B. Dale, “Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein,” Molecular Microbiology, vol. 59, no. 3, pp. 936–947, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. H. S. Courtney, S. K. Nishimoto, J. B. Dale, D. L. Hasty, and K. H. Schmidt, “Relative contributions of Serum Opacity Factor (SOF) and Streptococcal fibronectin-binding protein x (Sfbx) to the virulence of group A streptococci,” Current Trends in Microbiology, vol. 1, pp. 87–96, 2004. View at Google Scholar
  55. T. S. Parker, D. M. Levine, J. C. C. Chang, J. Laxer, C. C. Coffin, and A. L. Rubin, “Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood,” Infection and Immunity, vol. 63, no. 1, pp. 253–258, 1995. View at Google Scholar · View at Scopus
  56. C. Grunfeld, M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold, “Lipoproteins inhibit macrophage activation by lipoteichoic acid,” Journal of Lipid Research, vol. 40, no. 2, pp. 245–252, 1999. View at Google Scholar · View at Scopus
  57. A. Wu, C. J. Hinds, and C. Thiemermann, “High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications,” Shock, vol. 21, no. 3, pp. 210–221, 2004. View at Google Scholar · View at Scopus
  58. C. Tang, Y. Liu, P. S. Kessler, A. M. Vaughan, and J. F. Oram, “The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor,” Journal of Biological Chemistry, vol. 284, no. 47, pp. 32336–32343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. P. Molina-Portela, M. Samanovic, and J. Raper, “Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model,” Journal of Experimental Medicine, vol. 205, no. 8, pp. 1721–1728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Nizet, T. Ohtake, X. Lauth et al., “Innate antimicrobial peptide protects the skin from invasive bacterial infection,” Nature, vol. 414, no. 6862, pp. 454–457, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. E. Lau, D. M. E. Bowdish, C. Cosseau, R. E. W. Hancock, and D. J. Davidson, “Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 4, pp. 399–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Vaisar, S. Pennathur, P. S. Green et al., “Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 746–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. K.-A. Rye and P. J. Barter, “Antiinflammatory actions of HDL: a new insight,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, pp. 1890–1891, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. W. Khovidhunkit, M.-S. Kim, R. A. Memon et al., “Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host,” Journal of Lipid Research, vol. 45, no. 7, pp. 1169–1196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Urundhati, Y. Huang, J. A. Lupica, J. D. Smith, J. A. DiDonato, and S. L. Hazen, “Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle,” Journal of Biological Chemistry, vol. 284, no. 45, pp. 30825–30835, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Navab, G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, and A. M. Fogelman, “Mechanisms of disease: proatherogenic HDL—an evolving field,” Nature Clinical Practice Endocrinology and Metabolism, vol. 2, no. 9, pp. 504–511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. A. C. Almengor, M. S. Walters, and K. S. McIver, “Mga is sufficient to activate transcription in vitro of sof-sfbX and other Mga-regulated virulence genes in the group A streptococcus,” Journal of Bacteriology, vol. 188, no. 6, pp. 2038–2047, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. L. A. McLandsborough and P. P. Cleary, “Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that virR functions as a positive regulator of ScpA, FcRA, OF, and M protein,” FEMS Microbiology Letters, vol. 128, no. 1, pp. 45–51, 1995. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Podbielski, A. Flosdorff, and J. Weber-Heynemann, “The group A streptococcal virR49 gene controls expression of four structural vir regulon genes,” Infection and Immunity, vol. 63, no. 1, pp. 9–20, 1995. View at Google Scholar · View at Scopus
  70. M. G. Caparon and J. R. Scott, “Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 23, pp. 8677–8681, 1987. View at Google Scholar · View at Scopus
  71. B. Kreikemeyer, K. S. McIver, and A. Podbielski, “Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions,” Trends in Microbiology, vol. 11, no. 5, pp. 224–232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. K. S. McIver, A. S. Heath, and J. R. Scott, “Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription,” Infection and Immunity, vol. 63, no. 11, pp. 4540–4542, 1995. View at Google Scholar · View at Scopus
  73. M. G. Caparon, R. T. Geist, J. Perez-Casal, and J. R. Scott, “Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide,” Journal of Bacteriology, vol. 174, no. 17, pp. 5693–5701, 1992. View at Google Scholar · View at Scopus
  74. A. Podbielski, J. A. Peterson, and P. Cleary, “Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes,” Molecular Microbiology, vol. 6, no. 16, pp. 2253–2265, 1992. View at Google Scholar · View at Scopus
  75. J. C. Reitmeyer, R. K. Guthrie, and J. H. Steele, “The occurrence of nicotinamide adenine dinucleotide glycohydrolase and the serum opacity reaction in groups B, C, F and G streptococci,” Microbios, vol. 58, no. 236-237, pp. 183–187, 1989. View at Google Scholar · View at Scopus
  76. F. H. Top Jr. and L. W. Wannamaker, “The serum opacity reaction of Streptococcus pyogenes: frequency of production of streptococcal lipoproteinase by strains of different serological types and the relationship of M protein production,” Journal of Hygiene, vol. 66, no. 1, pp. 49–58, 1968. View at Google Scholar · View at Scopus
  77. D. R. Johnson, E. L. Kaplan, A. VanGheem, R. R. Facklam, and B. Beall, “Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor,” Journal of Medical Microbiology, vol. 55, no. 2, pp. 157–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. B. Luca-Harari, M. Straut, S. Cretoiu et al., “Molecular characterization of invasive and non-invasive Streptococcus pyogenes isolates from Romania,” Journal of Medical Microbiology, vol. 57, no. 11, pp. 1354–1363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. S. H. M. El Tayeb and E. M. M. Nasr, “Serum opacity factor of Staphylococcus epidermidis,” Infection and Immunity, vol. 15, no. 1, pp. 335–336, 1977. View at Google Scholar · View at Scopus
  80. V. Katerov, C. Schalen, and A. A. Totolian, “Sequencing of genes within the vir regulon of Streptococcus pyogenes type M15—an opacity factor positive serotype with low opacity factor expression,” Molecular and General Genetics, vol. 245, no. 1, pp. 78–85, 1994. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Takamatsu, K. Wongsawan, M. Osaki et al., “Streptococcus suis in humans, Thailand,” Emerging Infectious Diseases, vol. 14, no. 1, pp. 181–183, 2008. View at Google Scholar · View at Scopus
  82. J. B. Dale, T. Penfound, E. Y. Chiang, V. Long, S. T. Shulman, and B. Beall, “Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes,” Clinical and Diagnostic Laboratory Immunology, vol. 12, no. 7, pp. 833–836, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Schulze, E. Medina, S. R. Talay, R. J. Towers, G. S. Chhatwal, and C. A. Guzmán, “Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response,” Infection and Immunity, vol. 69, no. 1, pp. 622–625, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Schulze, E. Medina, and C. A. Guzmán, “Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain,” Vaccine, vol. 24, no. 9, pp. 1446–1450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. S. A. McNeil, S. A. Halperin, J. M. Langley et al., “Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers,” Clinical Infectious Diseases, vol. 41, no. 8, pp. 1114–1122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Yvan-Charvet, N. Wang, and A. R. Tall, “Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 139–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. H. J. Pownall and C. Ehnholm, “The unique role of apolipoprotein A-I in HDL remodeling and metabolism,” Current Opinion in Lipidology, vol. 17, no. 3, pp. 209–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. U. Tchoua, C. Rosales, B. K. Gillard et al., “Streptococcal serum opacity factor enhances macrophage cholesterol efflux and plasma cholesterol esterification,” submitted to The Journal of Biological Chemistry.
  89. N. Wang, D. L. Silver, P. Costet, and A. R. Tall, “Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1,” Journal of Biological Chemistry, vol. 275, no. 42, pp. 33053–33058, 2000. View at Google Scholar · View at Scopus
  90. W. S. Davidson, C. Rosales, B. Gillard et al., “Apolipoprotein A-I conformation in Streptococcal serum opacity factor-derived Neo HDL, a potent acceptor of macrophage cholesterol,” in Proceedings of the Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference, San Francisco, Calif, USA, 2010, abstract P89.
  91. C. Rosales, D. Tang, B. Gillard, H. S. Courtney, and H. J. Pownall, “Low dose Streptococcal serum opacity factor reduces plasma cholesterol in vivo,” in Proceedings of the Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference, San Francisco, Calif, USA, 2010, abstract P357.
  92. A. E. Frankel, B. L. Powell, N. S. Duesbery, G. F. Vande Woude, and S. H. Leppla, “Anthrax fusion protein therapy of cancer,” Current Protein and Peptide Science, vol. 3, no. 4, pp. 399–407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. M. de Maio, “Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders,” Expert Opinion on Biological Therapy, vol. 8, no. 6, pp. 791–798, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. N. Sikri and A. Bardia, “A history of streptokinase use in acute myocardial infarction,” Texas Heart Institute Journal, vol. 34, no. 3, pp. 318–327, 2007. View at Google Scholar · View at Scopus